Facebook
X
LinkedIn
Forward
Sponsored Webinar: At the Crossroads of NAD+ and Long COVID - Emerging Data on Nutrition Interventions
Free to all!
This webinar has been rescheduled for January 15, 2026. Thank you for your interest in this webinar!
Long COVID affects millions, with symptoms like fatigue, brain fog, and breathlessness lasting months post-infection. About 15% still experience symptoms a year later, driving urgent demand for effective treatments.
Niagen Bioscience co-funded a randomized, double-blind, placebo-controlled trial to evaluate NR (nicotinamide riboside) supplementation’s impact on NAD+ levels and long COVID symptoms.
Join us to explore the science behind NR and NAD+ in long COVID.
Sponsored by Niagen Bioscience, Inc.
Speakers
Impact of SARS-CoV-2 infection on NAD+ Metabolism: Implications for Long COVID
Charles Brenner, PhD
City of Hope
NAD+ Repletion for Long COVID: A Practitioner Perspective
Chris Meletis, ND
Naturopathic Doctor, Educator, International Author, and Lecturer
Learning Objectives
- Describe the role of NAD+ in the response to metabolic stress, including viral infection
- Explore the relationship between long COVID symptoms and NAD+ metabolism
- Describe the design and results of a recent intervention study involving nicotinamide riboside (NR) in individuals with Long COVID
- Review the healthcare practitioner perspective on the management of Long COVID
Available Credit
- 1.50 Attendance
Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.